mounjaro or tirzepatide is second obesity drug to be approved for use in England | Obesity How Mounjaro® Works for Weight

A label reflects regulator-reviewed information for a specific medicine, use, population, and formulation

Common adverse effects include gastrointestinal symptoms such as nausea, diarrhea, vomiting, and constipation, which typically diminish over time

These specialized regions relay peripheral signals into deeper brain areas without direct engagement of preproglucagon (PPG) neurons, which constitute the brains endogenous GLP-1 source (McLean et al., 2021)

Hypoglycemia risk remains low with this combination when used without insulin or sulfonylureas, as both medications have glucose-dependent mechanisms

In the SELECT trial, it reduced the risk of heart attack, stroke, and cardiovascular death by 20%, regardless of participants weight loss

Wait: Once no taste remains, you can eat or drink again